Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
228.1 USD | +0.40% | -2.62% | -1.42% |
Apr. 17 | Declaration of Voting Results by IQVIA Holdings | CI |
Apr. 10 | Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US | MT |
Financials (USD)
Sales 2024 * | 15.53B | Sales 2025 * | 16.66B | Capitalization | 41.35B |
---|---|---|---|---|---|
Net income 2024 * | 1.33B | Net income 2025 * | 1.58B | EV / Sales 2024 * | 3.44 x |
Net Debt 2024 * | 12.06B | Net Debt 2025 * | 11.62B | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
31.1
x | P/E ratio 2025 * |
26
x | Employees | 87,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.76% |
Latest transcript on Iqvia Holdings Inc.
1 day | +0.40% | ||
1 week | -2.62% | ||
Current month | -9.81% | ||
1 month | -10.26% | ||
3 months | +5.90% | ||
6 months | +22.14% | ||
Current year | -1.42% |
Managers | Title | Age | Since |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 63 | 16-10-02 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 63 | 20-07-31 |
James Berkshire
COO | Chief Operating Officer | 51 | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 16-10-02 |
Colleen Goggins
BRD | Director/Board Member | 68 | 17-07-26 |
Ari Bousbib
CEO | Chief Executive Officer | 63 | 16-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.67% | 0 M€ | 0.00% | - | |
3.45% | 0 M€ | 0.00% | - | |
2.92% | 1 M€ | 0.00% | - | |
2.68% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 228.1 | +0.40% | 756,510 |
24-04-18 | 227.2 | -0.04% | 631,234 |
24-04-17 | 227.2 | -0.82% | 705,876 |
24-04-16 | 229.1 | -0.87% | 920,953 |
24-04-15 | 231.2 | -1.31% | 609,477 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B | |
-19.49% | 9.78B |
- Stock Market
- Equities
- IQV Stock